http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110812362-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_553a717e2044255d07ffb86bdaf3bcd6 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-52 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52 |
filingDate | 2019-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e44aef35cebe4c43f575b950073bd80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d221f7a1eb125ec556c24b967c92d14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_589a7ea6a1349333e00be4fb64df6317 |
publicationDate | 2020-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-110812362-A |
titleOfInvention | Application of adenine in preparing medicine for treating β thalassemia |
abstract | The invention discloses application of adenine in preparing a medicine for treating β thalassemia, wherein the medicine for treating β thalassemia is a medicine with more than one function of improving the hematology phenotype of a β thalassemia patient, reducing the volume of red blood cells of a β thalassemia patient, reducing the iron content in the serum of a β thalassemia patient, reducing the liver iron content of a β thalassemia patient or improving the expression level of liver hepcidin mRNA. |
priorityDate | 2019-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 298.